Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease
Stopped low recruitment
Conditions
- Stenosis; Bowel
- Crohn Disease
Interventions
- DRUG: Adipose derived allogenic mesenchymal stem cells (adAMSC)
Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Collaborators